Effective Elimination of Cancer Stem Cells By a Novel Drug Combination Strategy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effective Elimination of Cancer Stem Cells By a Novel Drug Combination Strategy
Authors
Keywords
-
Journal
STEM CELLS
Volume 31, Issue 1, Pages 23-34
Publisher
Wiley
Online
2012-11-07
DOI
10.1002/stem.1273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
- (2011) Amparo Wolf et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
- (2011) Dagmar Beier et al. Molecular Cancer
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- Glycomic and Transcriptomic Response of GSC11 Glioblastoma Stem Cells to STAT3 Phosphorylation Inhibition and Serum-Induced Differentiation
- (2010) Huan He et al. JOURNAL OF PROTEOME RESEARCH
- A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo
- (2010) L. Yu et al. NEURO-ONCOLOGY
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate
- (2009) Zhao Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors
- (2009) Piotr Rieske et al. BMC CANCER
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Cancer stem cells: Cell culture, markers, and targets for new therapies
- (2009) Candace A. Gilbert et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
- (2009) P. Dell'Antone Medicinal Chemistry
- Bifunctional DNA Alkylator 1,3-Bis(2-chloroethyl)-1-nitrosourea Activates the ATR-Chk1 Pathway Independently of the Mismatch Repair Pathway
- (2009) B. Cui et al. MOLECULAR PHARMACOLOGY
- Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype
- (2009) T.-C. A. Johannessen et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Regulation of HIF-1α and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration
- (2009) Zhang Lei et al. PLoS One
- Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1
- (2008) Ana Paula Pereira Da Silva et al. BIOCHEMICAL JOURNAL
- 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
- (2008) Linda Strandberg Ihrlund et al. Molecular Oncology
- The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
- (2008) M Chekenya et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started